Osteoarthritis Trial, Recruiting NCT07558590 Sponsor: FX Solutions Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07558590
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a medical reason to need a partial or total shoulder replacement surgery using one of the FX Shoulder Solutions shoulder implant systems, as directed by their surgeon
  • People who are 18 years of age or older
  • People who are covered by a social security or health insurance system
  • People who have been fully informed about the study and have agreed to take part

Who may not be able to join:

  • People who have a neurological (nerve or brain-related) condition that affects the stability of the shoulder
  • People with severe obesity (confirm with trial site for specific definition used)
  • People who have significant muscle weakness or damage that affects how the shoulder joint works

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 800-280-0775

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
FX Solutions
Registry
ClinicalTrials.gov
Start date
1 June 2020
Est. completion
31 December 2036

Where this trial is recruiting

🇫🇷 France Monaco

Primary endpoints

Revision rate (KM) at 10 years postoperative

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov